From the Department of Medicine, University of Washington, Seattle (B.S., L.R.Z., J.W., J.H., J.B., K.E.B., I.H.d.B., J.W.H.).
Department of Pathology and Laboratory Medicine, University of Cincinnati, OH (W.S.D.).
Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1483-1491. doi: 10.1161/ATVBAHA.119.312556. Epub 2019 May 16.
Objective- Albuminuria is an important risk factor for cardiovascular disease in diabetes mellitus. We determined whether albuminuria associates with alterations in the proteome of HDL (high-density lipoprotein) of subjects with type 1 diabetes mellitus and whether those alterations associated with coronary artery calcification. Approach and Results- In a cross-sectional study of 191 subjects enrolled in the DCCT (Diabetes Control and Complications Trial)/EDIC study (Epidemiology of Diabetes Interventions and Complications), we used isotope dilution tandem mass spectrometry to quantify 46 proteins in HDL. Stringent statistical analysis demonstrated that 8 proteins associated with albuminuria. Two of those proteins, AMBP (α1-microglobulin/bikunin precursor) and PTGDS (prostaglandin-H2 D-isomerase), strongly and positively associated with the albumin excretion rate ( P<10). Furthermore, PON (paraoxonase) 1 and PON3 levels in HDL strongly and negatively associated with the presence of coronary artery calcium, with odds ratios per 1-SD difference of 0.63 (95% CI, 0.43-0.92; P=0.018) for PON1 and 0.59 (95% CI, 0.40-0.87; P=0.0079) for PON3. Only 1 protein, PON1, associated with both albumin excretion rate and coronary artery calcification. Conclusions- Our observations indicate that the HDL proteome is remodeled in type 1 diabetes mellitus subjects with albuminuria. Moreover, low concentrations of the antiatherosclerotic protein PON1 in HDL associated with both albuminuria and coronary artery calcification, raising the possibility that alterations in HDL protein cargo mediate, in part, the known association of albuminuria with cardiovascular risk in type 1 diabetes mellitus. Visual Overview- An online visual overview is available for this article.
目的-蛋白尿是糖尿病患者心血管疾病的一个重要危险因素。我们确定了 1 型糖尿病患者的高密度脂蛋白(HDL)中的蛋白质组是否与白蛋白尿有关,以及这些变化是否与冠状动脉钙化有关。
方法和结果-在 191 名参加糖尿病控制和并发症试验(DCCT)/ EDIC 研究(糖尿病干预和并发症的流行病学)的受试者的横断面研究中,我们使用同位素稀释串联质谱法定量测定了 HDL 中的 46 种蛋白质。严格的统计分析表明,有 8 种蛋白质与白蛋白尿有关。其中两种蛋白质,AMBP(α1-微球蛋白/ bikunin 前体)和 PTGDS(前列腺素 H2 D-异构酶),与白蛋白排泄率呈强烈正相关(P<10)。此外,HDL 中的 PON(对氧磷酶)1 和 PON3 水平与冠状动脉钙的存在呈强烈负相关,每 1-SD 差异的优势比分别为 0.63(95%CI,0.43-0.92;P=0.018)和 0.59(95%CI,0.40-0.87;P=0.0079)。只有 1 种蛋白质,PON1,与白蛋白排泄率和冠状动脉钙化都有关。
结论-我们的观察表明,在患有白蛋白尿的 1 型糖尿病患者中,HDL 蛋白质组发生了重塑。此外,HDL 中具有抗动脉粥样硬化作用的 PON1 浓度较低与白蛋白尿和冠状动脉钙化都有关,这提示 HDL 蛋白载体内的变化部分介导了白蛋白尿与 1 型糖尿病心血管风险的已知关联。
可视化概述-本文提供了一个在线可视化概述。